Letswin 2.5mg Tablet
Marketer
Mediwings Laboratories Pvt Ltd
Salt Composition
Letrozole (2.5mg)
Overview Letswin 2.5mg Tablet
Postmenopausal women with breast cancer may find relief with Estrostop 2.5mg tablets. This medication can be administered independently or alongside other therapies like surgery or radiotherapy. It's also indicated for advanced breast cancer to hinder metastasis. Estrostop 2.5mg tablets can be taken with or without food, following your doctor's prescribed dosage and duration for optimal results. Dosage varies depending on the treatment objective, determined by your physician to manage your symptoms effectively. Continue taking the medication for the prescribed period. Common side effects include night sweats, tiredness, excessive perspiration, and elevated cholesterol. Report any concerning side effects to your physician, who can offer management strategies. Before starting treatment, inform your physician of any pre-existing liver or kidney conditions, or a history of osteoporosis. Disclose all other medications you're currently using, as interactions can impact Estrostop's efficacy. If pregnant or breastfeeding, consult your doctor. Pre- and ongoing treatment may involve blood tests to monitor vitamin D levels and bone density.
Uses of Letswin 2.5mg Tablet
Managing Breast Cancer
Major Benefits of Letswin 2.5mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the 2.5mg Letswin Tablet whole; avoid chewing, crushing, or fracturing it. Consumption may coincide with meals or be taken independently, though consistent timing is recommended.
Common Side effects of Letswin 2.5mg Tablet:
- Dizziness
- Fatigue
- Weakness
- Bone pain
- Back pain
- Night sweats
- Joint pain
- Nausea
- Osteoporosis
- Joint inflammation
- Weight gain
- Hot flushes
- Edema (swelling)
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Diaphoresis
- Bone fracture
- Hypercholesterolemia (high cholesterol)
- Cough
- Shortness of breath
How to use Letswin 2.5mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the 2.5mg Letswin tablet whole; avoid chewing, crushing, or fracturing it. Consumption may coincide with meals or be taken independently, although consistent timing is recommended.
How Letswin 2.5mg Tablet works:
Estrogen production is reduced by Letswin 2.5mg Tablets, an aromatase inhibitor. This reduction in the body's estrogen levels can inhibit or halt the progression of certain estrogen-dependent breast cancers.
SAFETY ADVICE
AlcoholSAFE
Letswin 2.5mg Tablet consumption alongside alcohol does not produce adverse reactions.
PregnancyUNSAFE
Use of Letswin 2.5mg Tablets is strongly contraindicated during pregnancy. Pregnant women should consult their physician, as research in both animals and pregnant humans indicates substantial risks to the fetus.
Breast feedingUNSAFE
Administering Letswin 2.5mg tablets while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Driving may be impaired by Letswin 2.5mg Tablets, which can cause drowsiness, dizziness, and blurred vision. Refrain from operating a vehicle if you experience these effects.
KidneySAFE IF PRESCRIBED
Renal impairment does not necessitate a dosage change for Letswin 2.5mg Tablets, which are considered safe in such patients. Data regarding use in end-stage renal disease is, however, scarce. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Letswin 2.5mg Tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Letswin 2.5mg Tablet :
Should you forget a Letswin 2.5mg Tablet dose, administer it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Letswin 2.5mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Diphenylmethane-based compound |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
3,018 People bought this recently